Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Merville

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 13, 2020
An extension of the RITUX-ERAH study, multicenter randomized clinical trial comparing rituximab to placebo in acute antibody-mediated rejection after renal transplantationElodie Bailly, Simon Ville, Gilles Blancho, et al.
Transplantation|November 12, 2015
One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation: RITUX ERAH, a Multicenter Double-blind Randomized Placebo-controlled TrialBénédicte Sautenet, Gilles Blancho, Mathias Büchler, et al.
Kidney International|April 9, 2019
Epitope load identifies kidney transplant recipients at risk of allosensitization following minimization of immunosuppressionRenaud Snanoudj, Nassim Kamar, Elisabeth Cassuto, et al.
Immunity|June 14, 2015
OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper ResponseClément Jacquemin, Nathalie Schmitt, Cécile Contin-Bordes, et al.
Transplantation|March 28, 2003
A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipientsBernard Charpentier, Lionel Rostaing, Francois Berthoux, et al.
Nature|April 5, 2019
Author Correction: Targeted therapy in patients with PIK3CA-related overgrowth syndromeQuitterie Venot, Thomas Blanc, Smail Hadj Rabia, et al.
Journal of the American Society of Nephrology : JASN|March 10, 2019
Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell AntigensMarianne Delville, Baptiste Lamarthée, Sylvain Pagie, et al.
Nature|June 15, 2018
Targeted therapy in patients with PIK3CA-related overgrowth syndromeQuitterie Venot, Thomas Blanc, Smail Hadj Rabia, et al.
Kidney International Reports|December 19, 2024
Anti Phospholipase A2 Receptor 1 Antibodies and Membranous Nephropathy Recurrence After Kidney TransplantationMarion Cremoni, Maxime Teisseyre, Olivier Thaunat, et al.
BMJ Open|March 30, 2022
Impact of targeted hypothermia in expanded-criteria organ donors on recipient kidney-graft function: study protocol for a multicentre randomised controlled trial (HYPOREME)Noëlle Brulé, Emmanuel Canet, Morgane Péré, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 13, 2020
An extension of the RITUX-ERAH study, multicenter randomized clinical trial comparing rituximab to placebo in acute antibody-mediated rejection after renal transplantationElodie Bailly, Simon Ville, Gilles Blancho, et al.
Transplantation|November 12, 2015
One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation: RITUX ERAH, a Multicenter Double-blind Randomized Placebo-controlled TrialBénédicte Sautenet, Gilles Blancho, Mathias Büchler, et al.
Kidney International|April 9, 2019
Epitope load identifies kidney transplant recipients at risk of allosensitization following minimization of immunosuppressionRenaud Snanoudj, Nassim Kamar, Elisabeth Cassuto, et al.
Immunity|June 14, 2015
OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper ResponseClément Jacquemin, Nathalie Schmitt, Cécile Contin-Bordes, et al.
Transplantation|March 28, 2003
A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipientsBernard Charpentier, Lionel Rostaing, Francois Berthoux, et al.
Nature|April 5, 2019
Author Correction: Targeted therapy in patients with PIK3CA-related overgrowth syndromeQuitterie Venot, Thomas Blanc, Smail Hadj Rabia, et al.
Journal of the American Society of Nephrology : JASN|March 10, 2019
Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell AntigensMarianne Delville, Baptiste Lamarthée, Sylvain Pagie, et al.
Nature|June 15, 2018
Targeted therapy in patients with PIK3CA-related overgrowth syndromeQuitterie Venot, Thomas Blanc, Smail Hadj Rabia, et al.
Kidney International Reports|December 19, 2024
Anti Phospholipase A2 Receptor 1 Antibodies and Membranous Nephropathy Recurrence After Kidney TransplantationMarion Cremoni, Maxime Teisseyre, Olivier Thaunat, et al.
BMJ Open|March 30, 2022
Impact of targeted hypothermia in expanded-criteria organ donors on recipient kidney-graft function: study protocol for a multicentre randomised controlled trial (HYPOREME)Noëlle Brulé, Emmanuel Canet, Morgane Péré, et al.
Pageof 13